The ATXN2 CpG island has been studied in the context of spinocerebellar ataxias (SCAs) and differences in the disease course of SCA2 patients correlated with the different methylation level of the ATXN2 promoter [106]. Here, ATXN2 is linked to spinocerebellar ataxia type 2.